Q32 Bio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -121 | -123 | |
EBITDA | -17,798 | -14,720 | -2,155 |
EBIT | -17,919 | -14,843 | -2,198 |
Net Income | -16,978 | 1,029 | -16,119 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -22,229 | -14,551 | -21,575 |
Cash | 97,661 | 115,509 | 39,266 |
Basic Shares | 11,964 | 3,206 | 3,223 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,156 | $6,651 | $33,971 | $2,702 |
Gross Profit | 578 | 4,052 | 24,427 | 2,702 |
EBITDA | -86,502 | -38,855 | -86,220 | -121,359 |
EBIT | -87,080 | -41,454 | -95,764 | -130,263 |
Net Income | -112,961 | -42,809 | -37,564 | -128,693 |
Net Change In Cash | 1,156 | 6,651 | 33,971 | 2,702 |
Free Cash Flow | -96,458 | -13,442 | -33,136 | -98,065 |
Cash | 39,266 | 43,893 | 32,247 | 217,431 |
Basic Shares | 3,213 | 3,188 | 3,071 | 2,550 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.45 |
2024-06-30 | -$1.42 |
2024-03-31 | -$14.95 |
2023-12-31 | -$0.28 |
